News

Deal Announcements

Arstasis Adds Fifth Venture Capital Financing

Tuesday, June 7, 2011 5:34:00 AM PDT | VentureDeal Staff
   Redwood City, California  --  Medical device company Arstasis has received $25.5 million in its series E round of institutional venture capital investment, according to a report by Dow Jones.

Arstasis is commercializing what it calls an "innovative vascular access device designed to provide better solutions for arterial closure in catheterization procedures."

Investors in the financing were not disclosed. The company said it would use the proceeds for working capital and the launch of its flagship AXERA Access Device.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1